| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:11497 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of YWHAQ mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of YWHAQ mRNA | CTD | PMID:17108234 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11497 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of YWHAQ mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11497 | 6480464 | Tetrachlorodibenzodioxin affects the expression of YWHAQ mRNA | CTD | PMID:21570461 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of YWHAQ mRNA | CTD | PMID:21346803 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of YWHAQ mRNA | CTD | PMID:19162173 |
| 4-hydroxyphenyl retinamide | affects localization | ISO | RGD:734393 | 6480464 | Fenretinide affects the localization of YWHAQ protein | CTD | PMID:17110918 |
| acetylsalicylic acid | increases expression | ISO | RGD:734393 | 6480464 | Aspirin results in increased expression of YWHAQ mRNA | CTD | PMID:15928584 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of YWHAQ mRNA | CTD | PMID:16483693 |
| arsenite(3-) | multiple interactions | ISO | RGD:11497 | 6480464 | [arsenite results in increased phosphorylation of ZFP36 protein] promotes the reaction [ZFP36 protein binds to YWHAQ protein] | CTD | PMID:15014438 |
| benzene | multiple interactions | EXP | | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of YWHAQ mRNA | CTD | PMID:17905399 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11497 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of YWHAQ mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:11497 | 6480464 | Benzo(a)pyrene results in increased expression of YWHAQ mRNA | CTD | PMID:22228805 |
| bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of YWHAQ mRNA | CTD | PMID:15056800 |
| caffeine | multiple interactions | ISO | RGD:734393 | 6480464 | Caffeine inhibits the reaction [CDC25C protein binds to YWHAQ protein] | CTD | PMID:11835680 |
| copper(2+) sulfate | decreases expression | ISO | RGD:734393 | 6480464 | Copper Sulfate results in decreased expression of YWHAQ mRNA | CTD | PMID:19549813 |
| dibutyl phthalate | increases expression | ISO | RGD:11497 | 6480464 | Dibutyl Phthalate results in increased expression of YWHAQ mRNA | CTD | PMID:21266533 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of YWHAQ mRNA | CTD | PMID:16122865 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of YWHAQ gene | CTD | PMID:22079235 |
| hydralazine | multiple interactions | ISO | RGD:734393 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of YWHAQ mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | affects expression | ISO | RGD:734393 | 6480464 | Hydrogen Peroxide affects the expression of YWHAQ mRNA | CTD | PMID:20044591 |
| lithium atom | decreases expression | EXP | | 6480464 | Lithium results in decreased expression of YWHAQ protein | CTD | PMID:18296634 |
| methylmercury(1+) | multiple interactions | EXP | | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of YWHAQ mRNA | CTD | PMID:17905399 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of YWHAQ mRNA | CTD | PMID:19638242 |
| nonanoic acid | increases expression | ISO | RGD:11497 | 6480464 | pelargonic acid results in increased expression of YWHAQ mRNA | CTD | PMID:11379042 |
| paclitaxel | increases expression | ISO | RGD:734393 | 6480464 | Paclitaxel results in increased expression of YWHAQ protein | CTD | PMID:10822281 |
| phenethyl isothiocyanate | increases metabolic processing | ISO | RGD:734393 | 6480464 | phenethyl isothiocyanate results in increased metabolism of YWHAQ protein | CTD | PMID:21838287 |
| phenethyl isothiocyanate | affects binding | ISO | RGD:734393 | 6480464 | YWHAQ protein binds to phenethyl isothiocyanate | CTD | PMID:21838287 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of YWHAQ mRNA | CTD | PMID:19162173 |
| pirinixic acid | decreases expression | ISO | RGD:11497 | 6480464 | pirinixic acid results in decreased expression of YWHAQ mRNA | CTD | PMID:18445702 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of YWHAQ mRNA | CTD | PMID:19162173 |
| sulforaphane | increases metabolic processing | ISO | RGD:734393 | 6480464 | sulforafan results in increased metabolism of YWHAQ protein | CTD | PMID:21838287 |
| sulforaphane | affects binding | ISO | RGD:734393 | 6480464 | YWHAQ protein binds to sulforafan | CTD | PMID:21838287 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:11497 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of YWHAQ mRNA | CTD | PMID:11379042 |
| trichloroethene | multiple interactions | EXP | | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of YWHAQ mRNA | CTD | PMID:17905399 |
| uranium atom | affects expression | ISO | RGD:734393 | 6480464 | Uranium affects the expression of YWHAQ mRNA | CTD | PMID:15672453 |
| valproic acid | multiple interactions | ISO | RGD:734393 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of YWHAQ mRNA | CTD | PMID:17183730 |
| vincaleukoblastine | affects response to substance | ISO | RGD:734393 | 6480464 | YWHAQ protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 |